Literature DB >> 1703052

Excretion of beta 2-glycoprotein I (apolipoprotein H) in renal tubular disease.

A G Norden1, L M Fulcher, M Lapsley, F V Flynn.   

Abstract

beta 2-Glycoprotein I (beta 2GI) was identified as a major urinary protein excreted by patients with several renal tubular diseases, including adult Fanconi syndrome, nephrocalcinosis associated with autoimmune diseases, Lowe's syndrome, and Dent's disease (a familial renal tubular disease). Sixteen patients excreted between 2 and 40 mg of beta 2GI per millimole of creatinine. In contrast, 18 healthy controls had undetectable amounts of beta 2GI in urine. Isoelectric focusing followed by immunoblotting demonstrated multiple forms of beta 2GI with pls between 6.4 and 8.2. These pls are higher than for several other "tubular proteins"; beta 2GI may therefore be less retarded than more-anionic proteins by the glomerular charge-barrier. This could explain why large quantities of beta 2GI are excreted despite its relatively high molecular mass (50 kDa). Excretion of beta 2GI was easily demonstrated by routine electrophoresis of urine proteins. beta 2GI migrates in the beta-gamma region and may be confused with Bence Jones protein. beta 2GI is stable for at least two years in urine frozen at -25 degrees C.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1703052

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  Beta 2-glycoprotein-1 (apolipoprotein H) excretion in chronic renal tubular disorders: comparison with other protein markers of tubular malfunction.

Authors:  M Lapsley; P A Sansom; C T Marlow; F V Flynn; A G Norden
Journal:  J Clin Pathol       Date:  1991-10       Impact factor: 3.411

2.  beta2-glycoprotein-I (apolipoprotein H) and beta2-glycoprotein-I-phospholipid complex harbor a recognition site for the endocytic receptor megalin.

Authors:  S K Moestrup; I Schousboe; C Jacobsen; J R Leheste; E I Christensen; T E Willnow
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

3.  Beta 2-glycoprotein-1 (apolipoprotein H) excretion and renal tubular malfunction in diabetic patients without clinical proteinuria.

Authors:  M Lapsley; F V Flynn; P A Sansom
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

4.  Urinary excretion of beta 2-glycoprotein-1 (apolipoprotein H) and other markers of tubular malfunction in "non-tubular" renal disease.

Authors:  F V Flynn; M Lapsley; P A Sansom; S L Cohen
Journal:  J Clin Pathol       Date:  1992-07       Impact factor: 3.411

5.  Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache.

Authors:  Elisa Bellei; Emanuela Monari; Aurora Cuoghi; Stefania Bergamini; Simona Guerzoni; Michela Ciccarese; Tomris Ozben; Aldo Tomasi; Luigi Alberto Pini
Journal:  J Headache Pain       Date:  2013-01-30       Impact factor: 7.277

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.